The strategic use of biopsy in the diagnosis of coeliac disease in adults

• Published in: Digestive and liver disease Vol. 55; no. 12; pp. 1647 - 1651
• Main Authors: Deane, Charlene, O'Connor, Eoghan, O'Donovan, Helen, McHale, Ciaran, Alvain, Aoife, Shannon, Eileen, Tormey, Vincent, Hynes, Sean O, Byrnes, Valerie
• Format: Journal Article
• Language: English
• Published: Netherlands 01.12.2023
• Subjects: Adult; Autoantibodies; Biopsy; Celiac Disease; Child; Female; Humans; Immunoglobulin A; Male; Retrospective Studies; Transglutaminases; Accuracy; Serology; Diagnosis; Safety; Coeliac disease
• ISSN: 1590-8658; 1878-3562
• DOI: 10.1016/j.dld.2023.07.021

The paediatric guidelines support the use of the 'No Biopsy Approach' in the diagnosis of coeliac disease (CD). We aimed to determine the correlation between anti tissue transglutaminase (anti-TTG serology) ≥10 times the upper limit of normal (ULN), using the Celikey ® ELiA assay and histological findings. Our secondary aim was to determine the safety of this approach in our centre. A retrospective analysis of adult patients referred to a tertiary referral centre with raised anti-TTG titres and/or histological changes of coeliac on D2 biopsies between 2014 - 2019. Excluded patients were those who did not have a biopsy performed, or whose biopsy was unavailable for review, selective IgA deficiency, and gluten elimination prior to biopsy. Biopsies were classified according to Marsh, by two independent pathologists, blinded to the anti-TTG titre. 164 patients had positive anti-TTG serology and duodenal biopsy in our centre prior to starting a gluten free diet (GFD) in the period 2014 - 2019. Of these 164 patients (median age 40yrs, 62% female), 68 (33%) had an anti-TTG titre ≥10 x ULN, 99% of which had a Marsh grading ≥ 3 and 1% had a Marsh of 2 on biopsy. 91% had either a normal index gastroscopy or findings of mild gastritis/oesophagitis. We found a 98.5% positive predictive value (PPV) of determining CD (i.e., Marsh ≥ 3) in those with an anti-TTG ≥10 x ULN. In those with moderate to high-risk clinical suspicion of CD we propose that duodenal biopsy is unnecessary for diagnosis.